<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002725'>Systemic lupus erythematosus</z:hpo> (SLE) is an <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> characterized by disturbances in innate and adaptive immune mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain>Multiple systems and organs may be involved </plain></SENT>
<SENT sid="2" pm="."><plain>Tissue damage and dysfunction are mediated by autoantibodies and immune complex formation </plain></SENT>
<SENT sid="3" pm="."><plain>The lungs are among the organ systems commonly involved </plain></SENT>
<SENT sid="4" pm="."><plain>The pulmonary manifestations usually occur in patients with multisystem disease and include: pleural involvement, parenchymal <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">disease, pulmonary</z:e> <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> and diaphragmatic dysfunction </plain></SENT>
<SENT sid="5" pm="."><plain>Manifestations may range from sub-clinical abnormalities to life threatening disorders </plain></SENT>
<SENT sid="6" pm="."><plain>Many of the pulmonary manifestations characteristic of SLE are seen in the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) as well, in both the primary and secondary syndrome </plain></SENT>
<SENT sid="7" pm="."><plain>In this review the diverse pulmonary manifestations are described as well as the diagnostic modalities available, including the use of induced sputum evaluation for early diagnosis and follow up </plain></SENT>
<SENT sid="8" pm="."><plain>New treatment modalities are referred to </plain></SENT>
</text></document>